A carregar...
Therapeutic effects of calcium dobesilate on diabetic nephropathy mediated through reduction of expression of PAI-1
The aim of this study was to investigate whether calcium dobesilate (calcium dihydroxy-2,5-benzenesulfonate) may be used to treat diabetic nephropathy. A total of 121 patients with type 2 diabetic nephropathy received calcium dobesilate (500 mg, 3 times a day) for 3 months. The levels of glycated he...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3524077/ https://ncbi.nlm.nih.gov/pubmed/23251286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.755 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|